Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: FCA, bank competition, Glaxo

Sun, 30th Mar 2014 16:53

Big insurance companies want Martin Wheatley, Chief Executive of the Financial Conduct Authority, to resign after the watchdog sent their shares into freefall by making a misleading announcement about an industry probe, the Sunday Times said. The Association of British Insurers is expected to write to Chancellor George Osborne to complain about the FCA. Senior sources at four of Britain's biggest insurers told the paper Wheatley's position was untenable.Andrew Tyrie, Chairman of the Treasury Select Committee, has accused the Financial Conduct Authority of an "extraordinary blunder" in announcing market sensitive information about the insurance sector, the Sunday Telegraph reported. Insurer shares fell heavily on Friday after FCA Director of Supervision Clive Adamson told the Telegraph the watchdog planned an inquiry into pensions dating back to the 1970s. Tyrie said the FCA's pledge to bring in an external law firm to investigate the affair was not enough and that his committee would probably vet the inquiry head.The head of the Competition and Markets Authority (CMA) has said Labour leader Ed Miliband's plan for a swift breakup of Britain's banks is unworkable, the Sunday Telegraph reported. Alex Chisholm, Chief Executive of the new competition regulator, said an investigation would take at least 18 months and that any resulting disposals could take many years. Miliband said in January that a Labour government would introduce a threshold for personal current accounts and business banking and give the CMA six months to set the limit. Chisolm said the CMA, in shadow form, had been looking at small business banking for about six months.GlaxoSmithKline is planning a multimillion-pound investment in sub-Saharan Africa, the Sunday Telegraph reported. The pharmaceutical giant will announce plans to build up to five new factories on March 31st. It is looking at sites in Ghana, Ethiopia and Rwanda. Glaxo thinks Africa will be one of the fastest growing parts of the world over the next 50 years. Sub-Saharan Africa provides about £500m of Glaxo's £26.5bn annual sales.Land Securities has put on hold plans to build 200 luxury flats near Buckingham Palace until after next year's general election, the Sunday Times reported. The decision is the first sign that threats of a "mansion tax" are affecting developers' plans. The industry fears a 1% tax on homes worth more than £2m - a policy picked up by Labour that housebuilders are concerned the Conservatives will emulate.Royal Bank of Scotland is close to appointing Ewen Stevenson, one of the brains behind the 2008 banking bailout, as its new Finance Director, according to the Sunday Times. Stevenson, co-head of European investment banking at Credit Suisse, is said to have dreamt up the asset protection scheme insurance programme that stopped RBS shareholders being entirely wiped out during the financial crisis.A funding crisis has cast doubt on the future of Britain's second-biggest oil refinery, the Sunday Times said. The Stanlow plant is owned by Essar Energy, the Indian power and mining company whose founders are trying to buy it back after listing in London four years ago. Stanlow has to refinance a £330m loan from Barclays in July after using up £173m of its cash in the nine months to December. Essar said Stanlow was within its debt covenants and that the plant had the advantage of producing lots of diesel and jet fuel, of which the UK produces little.Real incomes in the UK are back to pre-financial crisis levels, the Sunday Times said. Figures in the small print of official figures released on March 28th showed real household disposable incomes were £507.7bn in the second half of last year - up 4% from the first half of 2008. Britain's population has risen in that time but by less than incomes. The figures suggest the squeeze on household budgets is easing fast.Card Factory is planning to join the line of retailers floating on the stock market with a share sale that could value the discount group at more than £700m, the Sunday Telegraph said. Its private equity owner, Charterhouse, is working on a flotation for this summer. Card Factory Chief Executive Richard Hayes told the paper he wanted to expand from 700 stores to as many as 1,100.A Chinese tycoon is in talks to buy House of Fraser for more than £450m, the Sunday Times reported. Yuan Yafei's Sanpower conglomerate has been in talks with House of Fraser for several months. The department store group's Chairman Don McCarthy has accepted the bid and has presented it to the company's other main shareholders for approval. The deal would end plans for House of Fraser to join the procession of retail initial public offerings.
More News
25 May 2023 10:42

IN BRIEF: Destiny Pharma picks interim CEO as Clark makes quick exit

Destiny Pharma PLC - Brighton, England-based clinical-stage biotechnology company focused on preventing life-threatening infections - Chief Executive Officer Neil Clark steps down immediately "to pursue new challenges". Clark will "support [Destiny] for a limited period to ensure an orderly handover." Non-Executive Director Debra Barker will serve as interim CEO until Destiny appoints a permanent replacement. Barker has held "key roles" at Novartis AG and Polyphor AG, now named Spexis AG. She also has previously worked at Roche Holding AG, Polyneuron Pharmaceuticals AG and GSK PLC.

Read more
15 May 2023 15:23

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

WASHINGTON, May 15 (Reuters) - The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc's challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication.

Read more
15 May 2023 14:37

US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute

WASHINGTON, May 15 (Reuters) - The U.S. Supreme Court on Monday declined to hear Teva Pharmaceuticals USA Inc's challenge to a $235 million award to GlaxoSmithKline LLC in a patent dispute over generic drugs involving a heart medication.

Read more
12 May 2023 16:53

LONDON MARKET CLOSE: Sterling slides after weak UK GDP print

(Alliance News) - Stocks in London ended the week broadly higher on Friday, with strong performances from blue-chips Beazley and GSK helping to offset weak economic growth data for the UK economy.

Read more
12 May 2023 12:10

LONDON MARKET MIDDAY: FTSE 100 outperforms as Beazley, GSK shine

(Alliance News) - Stock prices in London were mixed at midday on Friday as investors digested a weak GDP reading for the UK, a day after the Bank of England took the country's interest rates up to a 15-year-high.

Read more
12 May 2023 10:08

GSK hails 5-in-1 meningococcal ABCWY vaccine candidate trial data

(Alliance News) - GSK PLC on Friday reported positive preliminary results from a phase 3 trial regarding its 5-in-1 meningococcal ABCWY vaccine candidate.

Read more
12 May 2023 09:03

GSK sells $1 bln discounted stake in spin-off Haleon

GSK sells 240 mln Haleon shares at discount

*

Read more
12 May 2023 08:32

Canadian court dismisses GSK Zantac litigation

(Sharecast News) - A proposed class action against GSK has been dismissed by a court in Canada, the UK drugs giant confirmed on Friday.

Read more
12 May 2023 08:26

TOP NEWS: GSK welcomes legal ruling in Canada; sells Haleon shares

(Alliance News) - GSK PLC on Friday welcomed a legal ruling in Canada that threw out a proposed class action made on behalf of users of a heartburn drug.

Read more
12 May 2023 07:52

GSK sells 2.4% of Haleon stake via placing for £804m

(Sharecast News) - UK pharmaceuticals company GSK said it had sold a 2.5% stake in Haleon at 335p a share, raising £804m.

Read more
12 May 2023 07:50

LONDON BRIEFING: No Apollo offer for THG; GSK trims Haleon stake

(Alliance News) - Stocks in London were called to open higher on Friday, after data showed the UK economy expanded 0.1% over the first three months of the year.

Read more
4 May 2023 07:57

LONDON BRIEFING: Shell sets USD4 billion buyback; Next backs outlook

(Alliance News) - Stocks in London were called to open lower on Thursday, amid a busy day for company earnings and an interest rate decision by the EU's central bank in the afternoon.

Read more
3 May 2023 19:22

IN BRIEF: GSK receives FDA approval for Arexvy in older adults

GSK PLC - Brentford, London-based pharmaceutical firm - Announces the US Food & Drug Administration approves Arexvy, the world's first respiratory syncytial virus vaccine for older adults. States approval enables adults aged 60 years and older to be protected from RSV disease for the first time. Explains the approval is based on data from the positive pivotal AReSVi-006 phase III trial that showed exceptional efficacy in older adults, including those with underlying medical conditions, and in those with severe RSV disease. Plans US launch before the 2023/24 RSV season.

Read more
3 May 2023 17:24

London stocks gain ahead of Fed rate decision; Lloyds drags

Coca Cola HBC AG rises on upbeat forecast

*

Read more
3 May 2023 16:58

LONDON MARKET CLOSE: FTSE 100 in the green ahead of Fed rate decision

(Alliance News) - Stocks in London were higher at the close on Wednesday as investor waited with bated breath for the US Federal Reserve's next interest rate decision.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.